Aevi Genomic Medicine Provides Update on Sample Size Re-estimation for Phase 2 ASCEND Trial in ADHD

Author's Avatar
Jun 12, 2018
Article's Main Image

- Enrollment of ASCEND trial to be increased from 42 to 64 participants

- Top-line results expected during the fourth quarter 2018

PR Newswire